Needs & Objectives

Arizona United Rheumatology Alliance
2020 Annual Meeting

December 4 – 6, 2020
Enchantment Resort Hotel & Spa
Sedona, Arizona

Educational Needs

Gout is the most common form of inflammatory arthritis yet there remains a significant gap in the quality of care for patients with this disease. A review of the current available therapies as well as an understanding of the updated treatment guidelines will help the attendee begin to close these quality gaps.

Evaluation of a patient with a painful joint replacement is multifactorial and can influence a providers’ treatment or referral for treatment. Clinical evaluation, serological investigation, diagnostic imaging and microbiological analysis as well as patient reported outcome measurements (PROMs) are important to consider in order to recognize the underlying cause and refer.

In order to understand the effects of the supplements and complementary therapies rheumatology patients use, it is essential to increase the current knowledge base of rheumatologists. Many rheumatologists are unfamiliar with the scientific evidence for the use of supplements in the care of rheumatology patients and need exposure to the current data.

Chronic, low-grade inflammation can be a driver of numerous forms of chronic disease, which now account for more than 50% of all deaths. We now clearly recognize that acute inflammation is a critical part of our immune defenses against numerous dangers (i.e., infections, toxins, etc.); however, more recently we have recognized that chronic, low-grade inflammation can be a driver of numerous chronic diseases. These diseases include ischemic heart disease, stroke, Type-2 diabetes, neurodegenerative disorders, metabolic syndrome and a variety of autoimmune diseases.

It has been widely acknowledged that transition from adult to pediatric care is a vulnerable time for adolescents and young adults with rheumatic disease. Unfortunately, current primary and subspecialty care transitions and transfer processes remain inadequate. While improvement in the transition process in medical care has become a priority in many health care systems, the remains a significant gap in the evaluation of transition models and transition outcomes.

By recognizing ocular manifestations of systemic rheumatic/inflammatory diseases it is possible to avoid or at least delay long-term sequelae. A multidisciplinary approach between rheumatology and ophthalmology for the discovery and early management of these ocular manifestations is paramount in preserving visual function.

Sjögren’s syndrome, a chronic systemic autoimmune disease, is characterized by lacrimal and salivary gland inflammation with resultant dryness of the eyes and mouth. Although exocrine symptoms predominate extraglandular involvement is common. It is important to understand the current treatment recommendations and management options available.

Educational Objectives

At the conclusion of the 2020 AURA Annual Meeting, attendees will be able to:

  1. Design a comprehensive treatment plan to establish cure as the gout treatment target.
  2. Describe the benefits and risks of urate-lowering therapies, alone and in combination.
  3. Apply treatment strategies, including use of a treat-to-target approach, to achieve low urate levels, and minimize recurrent gout flares.
  4. Identify the common causes of postoperative pain in patients who have had hip and knee replacements.
  5. Explain how to work up a painful hip or knee replacement.
  6. Recognize what patients with a painful hip or knee replacement need referral to an Orthopedic Surgeon.
  7. Define the basic tenets defining Integrative Medicine.
  8. Recognize the role for select complementary therapies within a pharmaceutical regimen for arthritis.
  9. Describe the use and evidence for efficacy of several supplements, including fish oil and turmeric.
  10. Review dietary interventions and their effect on various rheumatological conditions.
    Safely recommend evidence-based, dietary supplements for select patients with rheumatological diseases.
  11. Describe the role in metainflammation in the pathogenesis of chronic diseases across the spectrum of aging. 
  12. Describe and correlate environmental and behavioral influences including diet, exercise, and stress as drivers of inflammation in patients with immune mediated disease.
  13. Critically appraise the data on wellness interventions that may complement traditional therapies of immune mediated diseases to improve health and quality of life.
  14. Describe unique health concerns of young adults with inflammatory arthritis, lupus and other rheumatologic disorders.
  15. Recognize importance of reproductive health concerns in young adults with rheumatic disease.
  16. Evaluate approaches that can optimize integration of young adults into a rheumatology practice.
  17. Explain the ophthalmic manifestations of common rheumatic diseases.
  18. Identify local therapies (i.e. those that are applied directly onto or into the eye) that may be required in addition to systemic medications for rheumatic diseases.
  19. Recognize ocular side-effects of some drugs used to treat rheumatic diseases.
  20. Review heterogeneity of clinical presentations.
  21. Discuss current evaluation and classification criteria.
  22. Describe Clinical practice guidelines and other aspects of management.
  23. Describe what a pharmacy benefit manager is and their role in the drug supply chain.
  24. Identify utilization management tools and what is the impact on patient's ability to access the correct medicine for them. 
  25. Review the latest state and federal regulatory and legislative issues affecting rheumatologists and their patients in Arizona.